Your session is about to expire
← Back to Search
Remote Smoking Cessation Intervention for Surgical Patients (BuTT-Out Trial)
N/A
Waitlist Available
Led By Susan M Lee, MD, FRCPC
Research Sponsored by Fraser Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a remote smoking cessation bundle to see if it's feasible and can reduce smoking rates and postoperative complications.
Who is the study for?
This trial is for adults over 18 who currently smoke cigarettes and have a surgery scheduled at least one week away or not yet booked. It's not for those needing emergency surgery, using non-cigarette tobacco, marijuana, or vaping products, pregnant or breastfeeding individuals, anyone unable to consent, or participants in other smoking cessation studies.
What is being tested?
The study tests a remote smoking cessation program designed to help smokers quit before their surgical appointments. The goal is to see if this virtual support can reduce the number of people who smoke and lower the risk of complications after surgery compared to standard advice.
What are the potential side effects?
Since this intervention involves counseling and support rather than medication, there are no direct side effects like you'd expect with drugs. However, quitting smoking can cause withdrawal symptoms such as irritability, cravings, and difficulty concentrating.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Smoke
Secondary study objectives
Change in smoking status from baseline
Cost of nicotine replacement therapy
Hospital Length of Stay
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
The intervention group will be emailed (or postal mailed) the smoking cessation bundle with educational video, brochure, referral to the Smokers' Helpline and direct referral to an online pharmacy for nicotine replacement.
Group II: Control groupActive Control1 Intervention
The control group will have their preadmission clinic telephone call as normal and may be given advice to quit smoking and information about available smoking cessation resources over the phone.
Find a Location
Who is running the clinical trial?
Fraser HealthLead Sponsor
46 Previous Clinical Trials
707,560 Total Patients Enrolled
Royal Columbian Hospital FoundationUNKNOWN
1 Previous Clinical Trials
70 Total Patients Enrolled
Susan M Lee, MD, FRCPCPrincipal InvestigatorFraser Health Authority
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You only smoke marijuana or use vaping products.You use tobacco products other than cigarettes, such as pipe tobacco or smokeless tobacco.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention group
- Group 2: Control group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger